Cargando…
Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand
Plasmodium vivax Duffy binding protein region II (DBPII) is an important vaccine candidate for antibody-mediated immunity against vivax malaria. A significant challenge for vaccine development of DBPII is its highly polymorphic nature that alters sensitivity to neutralizing antibody responses. Here,...
Autores principales: | Chootong, Patchanee, Panichakul, Tasanee, Permmongkol, Chongrak, Barnes, Samantha J., Udomsangpetch, Rachanee, Adams, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338783/ https://www.ncbi.nlm.nih.gov/pubmed/22558221 http://dx.doi.org/10.1371/journal.pone.0035769 |
Ejemplares similares
-
Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein
por: Grimberg, Brian T, et al.
Publicado: (2007) -
Suppression of erythropoiesis by Plasmodium vivax infection
por: Panichakul, Tasanee, et al.
Publicado: (2010) -
Suppression of erythroid development in vitro by Plasmodium vivax
por: Panichakul, Tasanee, et al.
Publicado: (2012) -
Characterization of Duffy Binding Protein II-specific CD4(+)T cell responses in Plasmodium vivax patients
por: Thawornpan, Pongsakorn, et al.
Publicado: (2023) -
Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin
por: Panichakul, Tasanee, et al.
Publicado: (2015)